SCHEMBL13020361

SCHEMBL13020361

O=Cc1cccn(Cc2ccc(Br)cc2)c1=O

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC3 O15379 10/20 0.64
▸ HDAC4 P56524 10/20 0.64
▸ HDAC1 Q13547 10/20 0.64
▸ HDAC7 Q8WUI4 10/20 0.64
▸ HDAC2 Q92769 10/20 0.64
▸ HDAC10 Q969S8 10/20 0.64
▸ HDAC11 Q96DB2 10/20 0.64
▸ HDAC8 Q9BY41 10/20 0.64
▸ HDAC6 Q9UBN7 10/20 0.64
▸ HDAC9 Q9UKV0 10/20 0.64
▸ HDAC5 Q9UQL6 10/20 0.64
▸ VEGFA P15692 1/20 0.45
▸ EGLN1 Q9GZT9 1/20 0.45
▸ MAPT P10636 3/20 0.41
▸ TP53 P04637 1/20 0.41
▸ THRB P10828 1/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.40
▸ BRD4 O60885 2/20 0.40
▸ BRD2 P25440 1/20 0.40
▸ BRD3 Q15059 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19723217 0.85 BRD4 (0.54) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL28477450 0.80 ALDH1A1 (0.49) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL13020120 0.78 HDAC3 (1.00) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL4540682 0.78 PDPK1 (0.45) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL29348731 0.78 HDAC3 (0.52) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL13332848 0.77 SMN1; SMN2 (0.44) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL13020273 0.76 HDAC3 (0.74) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL13020114 0.75 HDAC3 (0.53) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL4437360 0.74 BRD4 (0.56) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL14322593 0.74 LMNA (0.53) HDAC3HDAC4HDAC1HDAC7HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010140835-A2 NOVEL PYRIDONE COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, METHOD FOR PRODUCING THE SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME FOR TREATING CANCER 연세대학교 산학협력단 (KR) 2010-12-09 — — WO disclosed
Send feedback